CClinicalTrials.gg
CompletedNCT02771522Updated Feb 28, 2019Results posted

Caries Lesion Activity in Orthodontic Patients - Calcivis System

An interventional study of Calcivis System in Dental Caries, sponsored by Calcivis Ltd. Completed at 1 site in United Kingdom. Open to participants aged 12 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-02-28.

Sponsored by Calcivis Ltd · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
12 Years to 100 Years
Sex
All
01

Study summary

This is a prospective, single-centre clinical study to monitor caries lesion activity in orthodontic patients with the Calcivis System over a 12 week period. Dentists will identify patients who have had dental appliances in place for a minimum of 12 months and have visible white spot lesions on the anterior surfaces of incisors and / or canines at de-bond. Following de-bond, images of the tooth surface will be taken with the Calcivis System. Presence or absence of elevated luminescence on the images will indicate activity / inactivity. Only patients with at least one tooth identified as active with the Calcivis System will continue in the study and be followed up at 2, 4, 8 and 12 weeks de-bond. Images of the active teeth will be taken with the Calcivis System as before, at each follow-up visit.

The percentage of teeth showing luminescence using the Calcivis System will be calculated and summarised for all subjects for each post-baseline visit, and additionally by Investigator. This will then be summarised over all subjects for each post-baseline visit.

Read the detailed description

Dental caries (tooth decay) is a significant clinical and public health problem. The development of caries lesions involves a net mineral loss of dental tissue, which can lead to progressive loss of tooth structure and associated pain and disease. Detecting, assessing, diagnosis and treating such lesions are core activities in dentistry. Currently the main detection and diagnosis aids are visual inspection and the used of a probe, together with X-ray images. Determination of the activity status of a lesion (how likely it is to progress) is requires to assess treatment needs. Currently methods are problematic and involve the clinicians' subjective assessment and / or monitoring of lesions progression over a number of visits.

It is generally recognised and reported in the dental literature that patients undergoing orthodontic treatment with fixed appliances find it difficult to maintain meticulous oral hygiene and that, as a result, plaque accumulates adjacent to the orthodontic brackets (which are usually placed on the buccal, Free Smooth, surfaces of teeth, which are readily visible) holding the metal wires which are involved in moving the teeth - thus white spot lesions commonly develop at these sites of plaque stagnation. These lesions are, de facto, actively developing during orthodontic treatment, thus represent 'active lesions'. Once the wires and brackets are removed post-treatment, normal oral hygiene can be resumed, the plaque/biofilm over these lesions is readily removed and they become arrested, i.e. the demineralisation process ceases. Thus during a short period of time - a matter of weeks - there is usually a transition from active to inactive status for these 'orthodontically-induced' white spot lesions. By assessing and monitoring these lesions, using the Calcivis device, at relatively short intervals during this period of lesion status transition immediately post orthodontic treatment it would be possible to monitor the reduction in the demineralisation process as these lesions arrest.

A previous clinical study on the prototype of the Calcivis System has been conducted. The results concluded that the Calcivis System was safe for use and the level of agreement between elevated luminescence and areas of expected activity was above 70% and not due to chance (NCT02098304).

This prospective, single-centre clinical study has been designed to assess the use of the Calcivis System for monitoring the activity levels of post-orthodontic treatment white spot lesions over time. The Dentist will share the images with the patient

The device under evaluation comprises a hand-held customized intra-oral camera which takes both black \& white and luminescent images of a lesion on a tooth surface while simultaneously applying a photoprotein solution. The photo-protein detects free calcium ions on the tooth surface and produces a light signal if the caries lesion is active.

For the study, patients attending routine Orthodontic appointments to have their appliances checked, and who are identified by the Investigator as meeting the Inclusion and Exclusion criteria, and are ready for de-bond, will be approached to discuss their possible participation in the study.

Patients will be given a Patient Information Sheet to read and time to consider their participation in the study. If they are happy to participate they will asked to attend for five Study Visits - de-bond (baseline), 2, 4, 8 and 12 weeks. Written informed consent will be taken before any study procedures are conducted. As children under the age of 16 are included in this study, parent / guardian consent will be taken where appropriate.

At study Visit 1, demographics, relevant medications, oral hygiene and orthodontic history data will be collected.

The orthodontist will carry out an oral examination and the tooth / teeth identified as per inclusion / exclusion criteria, will be cleaned with prophy paste, rinsed with tap water and a 3-in-1 air / water spray before being air dried and staged as per ICDAS coding. Reference intra-oral photographs will be taken of each tooth. The free smooth tooth surfaces will again be air dried before taking the black \& white and luminescent images with the Calcivis System. After imaging is completed, patients rinse out with tap water. Adverse event will be collected throughout. The dentist will then share the images of the teeth with the patient. Post imaging questionnaires will be completed by each patient at the end of Study Visit 1 and user questionnaires completed by the dental team at the end of each Study Visit 1 day.

Only patients who have 'active' lesions on de-bond, as confirmed with the Calcivis System at the baseline visit, will be followed up in this study. If all lesions are assessed as 'inactive', the patient will be withdrawn from the study

Eligible patients will return for Study Visits at 2, 4, 8 and 12 weeks post-de-bond. At each of these visits, following a reference photograph of the teeth, each tooth which was "active" at Study Visit 1 will again be imaged with the Calcivis System as described above and the images shared with the patient. In addition, both Patient and User Questionnaires will be completed at the final Study Visit at 12 weeks.

02

Conditions studied

  • Dental Caries

Browse trials for

Keywords

  • Caries, Acitivity, Demineralsiation
03

In context

Dental Caries

1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.

This study's enrollment of 36 is below the median of 60 across 916 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Calcivis Ltd is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patient must be ≥ 12 years old
  2. Patient must have had orthodontic appliances placed on the upper incisors and / or canines for at least 12 months, and be ready for de-bond
  3. Patient must have at least one, active white spot lesion identified by the Calcivs System immediately post de-bond
  4. Patient and / or parent or guardian must be willing and able to give written informed consent
  5. Patient and / or parent or guardian must be willing and able to adhere to study schedule

Exclusion criteria

Exclusion Criteria:

  1. Any Patient with recent tooth bleaching (within previous two weeks of imaging with the Calcivis System) or within the follow-up period
  2. Any patient currently taking part in a clinical research study, or who has taken part in a clinical research study in the previous three months
  3. Pregnant and / or nursing mothers
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Other
    Active post-othodontic lesions

    Imaging with the Calcivis System

    Device: Calcivis System

Interventions

  • DeviceCalcivis System

    Following de-bond, and identification of active post-orthodontic white spot lesions at baseline with the Calcivis System, each active tooth will be again be imaged at 2, 4, 8 and 12 weeks. Both black \& white and luminescent images images of the teeth are taken. The images of each tooth are overlaid and a resulting demineralization map of the tooth produced, indicating areas of elevated bioluminescence corresponding to free calcium ions on the surface of the tooth (active caries)

    Also known as: Calcivis Caries Activity Imaging System

06

What researchers measure

Primary outcomes

  1. Presence or Absence of Elevated Luminescence

    Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time

    Time frame: 0, 2, 4, 8 and 12 weeks

  2. Presence or Absence of Elevated Luminescence

    Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator

    Time frame: 0, 2, 4, 8 and 12 weeks post de-bond

Secondary outcomes

  1. Number of Non-patient Related Adverse Events With the Calcivis System

    All adverse events and device deficiencies were collected throughout the study on Adverse Event Forms

    Time frame: 0 days, 2, 4, 8 and 12 weeks

  2. Patient Experience

    Completion of Patient Questionnaires after imaging with the Calcivis System

    Time frame: Baseline

  3. Patient Experience

    Completion of Patient Questionnaires after imaging with the Calcivis System at patient's final visit

    Time frame: Final Visit - either 8 or 12 weeks post debond

  4. User Questionnaires

    Completion of User Questionnaires after imaging with the Calcivis System

    Time frame: Baseline visit

07

Results

Posted Feb 28, 2019

Participant flow

Patients were recruited by two Investigators from a routine NHS Orthodontic clinic between 15 February 2017 and 01 May 2018. Of the 36 patients attending Visit 1, 30 were eligible for Calcivis imaging ( 3 patients were pregnant, 2 patients had appliances on less than 12 months and I patient did not have visible white spot lesions).

Participant flow — Overall Study
MilestoneActive Post-othodontic Lesions
Started30
Completed22
Not completed8
Withdrew: Lost to follow-up3
Withdrew: Withdrawal by subject2
Withdrew: No white spot lesions3

Outcome measures

PrimaryPresence or Absence of Elevated Luminescence

Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time

Time frame:
0, 2, 4, 8 and 12 weeks
Reported as:
Number · % active teeth with luminescence
Presence or Absence of Elevated Luminescence
% active teeth with luminescenceActive Post-othodontic Lesions
Baseline61.7
2 weeks post de-bond17.3
4 weeks post de-bond6.0
8 weeks post de-bond10.2
12 weeks post de-bond6.3
PrimaryPresence or Absence of Elevated Luminescence

Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator

Time frame:
0, 2, 4, 8 and 12 weeks post de-bond
Reported as:
Number · % active teeth with luminescence
Presence or Absence of Elevated Luminescence
% active teeth with luminescencePost-orthodontic Lesions
Site 11 - Baseline58.9
Site 11 - 2 weeks post de-bond11.4
Site 11 - 4 weeks post de-bond2.6
Site 11 - 8 weeks post de-bond6.3
Site 11 - 12 weeks posar de-bond8.3
Site 31 - Baseline100.0
Site 31 - 2 weeks post debond50.0
Site 31 - 4 weeks posat de-bond37.5
Site 31 - 8 weeks post de-bond50.0
Site 31 - 12 weeks post de-bond0.0
SecondaryNumber of Non-patient Related Adverse Events With the Calcivis System

All adverse events and device deficiencies were collected throughout the study on Adverse Event Forms

Time frame:
0 days, 2, 4, 8 and 12 weeks
Reported as:
Number · Non-patient-related Adverse Events
Number of Non-patient Related Adverse Events With the Calcivis System
Non-patient-related Adverse EventsActive Post-othodontic Lesions
Number of Non-patient Related Adverse Events With the Calcivis System3
SecondaryPatient Experience

Completion of Patient Questionnaires after imaging with the Calcivis System

Time frame:
Baseline
Reported as:
Number · participants
Patient Experience
participantsPost-orthodontic Lesions
Calcivis System experience:good27
Calcivis System experience:neither good nor bad3
Calcivis System experience:bad0
Calcivis System - seeing images:helpful30
CalcivisSystem-images-neither good nor bad0
CalcivisSystem - seeing images - bad0
SecondaryPatient Experience

Completion of Patient Questionnaires after imaging with the Calcivis System at patient's final visit

Time frame:
Final Visit - either 8 or 12 weeks post debond
Reported as:
Number · Participants
Patient Experience
ParticipantsPost-orthodontic Lesions
Calcivis System experienc: good16
Calcivis System experience: neither good nor bad2
Calcivis System experience: bad0
Calcivis System-seeing images: helpful18
CalcivisSystem images:neitherhelpfuln0
Calcivis System - seeing images: unhelpful0
SecondaryUser Questionnaires

Completion of User Questionnaires after imaging with the Calcivis System

Time frame:
Baseline visit
Reported as:
Number · User Questionniares
User Questionnaires
User QuestionniaresActive Post-othodontic Lesions
Calcivis System preparation:easy21
CalcivisSystempreparation:neithereasynordifficult9
Calcivis system preparation: difficult0
Calcivis System use: easy17
Calcivis System use: neither easy nor difficult11
calcivis System use: difficult2
Calcivis System experience: good24
Calcivis System experience:neither good nor bad4
Calcivis System experience: bad2
Understand instructions:easy19
Understand instructions:neither easy nor difficult11
Understand instructions: difficult0

Adverse events

Collected over 12 weeks post baseline visit. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Active Post-othodontic Lesions0/30 (0%)0/30 (0%)3/30 (10%)
Most frequent other events
Most frequent other events
EventActive Post-othodontic Lesions
non patient related adverse eventsProduct Issues3/30

Baseline characteristics

Of the 30 patients, 119 teeth were imaged

Age, Continuous
Age, Continuous(years)Active Post-othodontic Lesions
Mean19.9 ± 6.52
Sex: Female, Male
Sex: Female, Male(Participants)Active Post-othodontic Lesions
Female16
Male14
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Active Post-othodontic Lesions
Region of Enrollment
Region of Enrollment(participants)Active Post-othodontic Lesions
United Kingdom30
Number of teeth imaged and deemed active
Number of teeth imaged and deemed active(Teeth)Active Post-othodontic Lesions
Number73
08

Study locations

1 site
  • Edinburgh Dental Institute
    Edinburgh, EH3 9HA, United Kingdom
09

References and documents

Study documents

  • Statistical analysis plan · Apr 25, 2018
  • Study protocol · Nov 8, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02771522
Lead sponsor
Calcivis Ltd
Collaborators
Medsource UK Ltd.
Responsible party
Sponsor
First posted
May 13, 2016
Start date
Feb 15, 2017
Primary completion
Jun 5, 2018
Completion
Jun 5, 2018
Results posted
Feb 28, 2019
Last update
Feb 28, 2019

Study contacts

Aman Ulhaq, BDS, MFDS, MSc, MOrtho
study director · Edinburgh Dental Institutie
Niall McGuinness, FDS, MOrth, MSCD, DDS, PhD
principal investigator · Edinburgh Dental Institute
Eamon Howard-Bowles, BDS, MFDS, PG Cert
principal investigator · Edinbuirgh Dental Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion